Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report GlobeNewswire - Thu Dec 12, 6:30AM CST

RGEN : 144.46 (-1.42%)
Repligen Corporation Launches AVIPure® dsRNA Clear OPUS® Columns to Enhance mRNA Therapeutics Production Quiver Quantitative, Inc. - Mon Dec 9, 4:50PM CST

Repligen launches AVIPure dsRNA Clear OPUS columns for improved mRNA therapeutic production, enhancing dsRNA impurity removal efficiency.Quiver AI SummaryRepligen Corporation has launched its AVIPure®...

RGEN : 144.46 (-1.42%)
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns GlobeNewswire - Mon Dec 9, 6:30AM CST

RGEN : 144.46 (-1.42%)
Insider Sale: Director at $RGEN (RGEN) Sells 24,246 Shares Quiver Quantitative, Inc. - Sat Nov 23, 2:08AM CST

Anthony Hunt, a director at $RGEN ($RGEN), sold 24,246 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.8% of their shares....

RGEN : 144.46 (-1.42%)
Repligen: Q3 Earnings Snapshot AP - Tue Nov 12, 7:00AM CST

Repligen: Q3 Earnings Snapshot

RGEN : 144.46 (-1.42%)
Repligen Reports Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 6:30AM CST

RGEN : 144.46 (-1.42%)
Repligen Corporation to Present at Upcoming Investor Conferences GlobeNewswire - Tue Nov 5, 6:30AM CST

RGEN : 144.46 (-1.42%)
Repligen to Report Third Quarter 2024 Financial Results GlobeNewswire - Thu Oct 31, 6:30AM CDT

RGEN : 144.46 (-1.42%)
Here's Why Shares in This Hot Healthcare Stock Surged This Week Motley Fool - Fri Aug 2, 6:09AM CDT

The bioprocessing market is preparing for a recovery.

RGEN : 144.46 (-1.42%)
Repligen: Q2 Earnings Snapshot AP - Tue Jul 30, 6:45AM CDT

Repligen: Q2 Earnings Snapshot

RGEN : 144.46 (-1.42%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot